Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Strata Critical Medical, Inc.NASDAQ: SRTA

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow turns negative

Q1 FY2026 financing cash flow was -$530K, compared with $60K a year earlier. Trailing-twelve-month financing cash flow was -$9.5M. Over 3 fiscal years it compounded at +101.8% a year.

Context

  • Financing cash flow amounted to 4.5% of revenue in FY2025, up 2.2 pp from a year earlier.
  • Financing cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near -$530K or moves back toward the trailing-twelve-month quarterly average of -$2.38M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$530K-69.6% QoQ
Last fiscal yearDec 2025
-$8.91M+54.7% YoY
LTMMar 2026
-$9.5M+45.5% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-983.3%——
1 year+54.7%——
3-year CAGR+101.8%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(8.91M) USD
Year-over-year change
-54.7%

Financing Cash Flow vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +45.5% is the 3rd highest of 9, against a peer median of -38.2%.
  • Financing cash flow amounts to 3.7% of revenue for SRTA, versus a peer median of 10.3%.
SRTA Competitors
Financing Cash Flow for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVTLVertical Aerospace Ltd.LTM Mar 2026£119.15M GBP—+158.4%—
ZIPZipRecruiter, Inc.LTM Mar 2026$90.26M USD+35.6%—20.2%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$83.93M USD—+163.0%95.4%
FLYXflyExclusive, Inc.LTM Mar 2026$49.27M USD-45.2%—12.8%
KFRCKforce Inc.LTM Mar 2026$43.79M USD-31.2%-35.9%3.3%
EBFEnnis, Inc.LTM Feb 2026$40.32M USD-57.0%+14.4%10.3%
CYRXCryoport, Inc.LTM Mar 2026$20.8M USD-87.2%-18.7%11.4%
ORNOrion Group Holdings, Inc.LTM Mar 2026$16.09M USD+413.0%+67.6%1.8%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$9.5M USD+45.5%+101.8%3.7%
MTRXMatrix Service CompanyLTM Mar 2026$4.18M USD+304.4%—0.5%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$1.09M USD-99.6%—0.1%
Peer median (excluding SRTA) —-38.2%+41.0%10.3%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.